CUMBERLAND PHARMACEUTICALS INC Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2024.
  • Cumberland Pharmaceuticals Inc Costs and Expenses for the quarter ending June 30, 2024 was $10.9M, a 0.09% increase year-over-year.
  • Cumberland Pharmaceuticals Inc Costs and Expenses for the twelve months ending June 30, 2024 was $48.7M, a 8.95% increase year-over-year.
  • Cumberland Pharmaceuticals Inc annual Costs and Expenses for 2023 was $49.1M, a 2.92% increase from 2022.
  • Cumberland Pharmaceuticals Inc annual Costs and Expenses for 2022 was $47.7M, a 9.28% increase from 2021.
  • Cumberland Pharmaceuticals Inc annual Costs and Expenses for 2021 was $43.7M, a 0.37% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $48.7M $10.9M +$9.52K +0.09% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $48.7M $10.4M -$389K -3.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $49.1M $15.5M +$4.13M +36.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $45M $12M +$251K +2.14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $44.7M $10.9M -$1.28M -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $46M $10.8M -$1.71M -13.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $47.7M $11.4M -$1.27M -10% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $49M $11.7M +$2.07M +21.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $46.9M $12.1M +$1.65M +15.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $45.3M $12.5M +$1.61M +14.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $43.7M $12.7M +$666K +5.55% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $43M $9.64M -$823K -7.87% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $43.8M $10.5M -$688K -6.15% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $44.5M $10.9M +$685K +6.73% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $43.8M $12M -$692K -5.45% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $44.5M $10.5M +$328K +3.23% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $44.2M $11.2M +$388K +3.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $43.8M $10.2M +$123K +1.22% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $43.7M $12.7M +$4.55M +55.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $39.1M $10.1M -$168K -1.63% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $39.3M $10.8M -$242K -2.19% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $39.5M $10.1M -$986K -8.93% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $40.5M $8.15M +$5.62M +223% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $34.9M $10.3M -$1.74M -14.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $36.6M $11M +$685K +6.62% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $35.9M $11M +$745K +7.24% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $35.2M $2.52M -$7.52M -74.9% Oct 1, 2017 Dec 31, 2017 8-K 2020-12-10
Q3 2017 $42.7M $12M +$3.37M +39% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $39.3M $10.3M +$2.83M +37.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $36.5M $10.3M +$2.06M +25% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $34.5M $10M +$2.16M +27.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 $32.3M $8.66M +$1.05M +13.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $31.2M $7.52M -$716K -8.69% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $32M $8.24M -$445K -5.12% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $32.4M $7.87M -$508K -6.07% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $32.9M $7.61M -$1.13M -12.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $34M $8.24M -$299K -3.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $34.3M $8.68M +$997K +13% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $33.3M $8.38M -$2.25M -21.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 $35.6M $8.74M +$697K +8.66% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $34.9M $8.53M +$313K +3.81% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $34.6M $7.69M -$1.25M -14% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $35.8M $10.6M +$188K +1.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $35.6M $8.04M -$1.51M -15.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $37.1M $8.22M -$2.21M -21.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $39.4M $8.93M -$678K -7.06% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $40M $10.4M -$877K -7.75% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-09
Q3 2012 $40.9M $9.55M -$403K -4.05% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $41.3M $10.4M -$331K -3.08% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $41.6M $9.61M +$351K +3.79% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $41.3M $11.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-11
Q3 2011 $9.96M +$209K +2.14% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $10.8M +$1.03M +10.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $9.26M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $9.75M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $9.73M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.